MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
bio-techne-logo-ai
BIO-TECHNE Corp (TECH)
bio-techne-logo-ai
BIO-TECHNE Corp (TECH)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Free Cash flow
$263,223K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net earnings
Depreciation and amortization
Proceeds from stock option exerc...
Others
Negative Cash Flow Breakdown
Repayments of long-term debt
Cash dividends
Repurchases of common stock
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2026-06-30
2025-06-30
2024-06-30
2023-06-30
Net earnings
181,862
73,400
168,105
285,442
Depreciation and amortization
97,359
109,903
111,711
107,238
Costs recognized on sale of acquired inventory
-
751
729
400
Deferred income taxes
13,196
-51,107
-39,447
-29,567
Stock-based compensation expense
41,365
40,833
38,042
39,230
Fair value adjustment to contingent consideration payable
-
-
-3,500
-12,100
(gain) loss on investment, net
-
-
-
37,176
Fair value adjustment on available-for-sale investments
-
-
-283
-472
(gain) loss on equity method investment
887
938
-
-1,143
Loss on equity method investment
-
-
6,841
-
Loss on investments
-5,862
-
-
-
Gain on sale of eminence
-
-
-
11,682
Asset impairment restructuring
3,914
21,312
2,634
-
Leases, net
-2,983
685
1,708
2,059
Impairment (recovery) of assets held-for-sale
-
80,503
21,963
-
(recovery) impairment of assets held-for-sale
-6,789
-
-
-
Other operating activity
477
675
584
455
Trade accounts and other receivables, net
10,793
-34,132
20,533
20,867
Inventories
8,232
18,144
14,215
30,167
Prepaid expenses
-5,264
14,372
3,146
4,585
Trade accounts payable, accrued expenses, contract liabilities, and other
3,180
-13,954
25,769
-7,908
Salaries, wages and related accruals
-7,671
15,408
12,618
-24,558
Income taxes payable
-23,051
8,469
-10,599
-2,492
Net cash provided by operating activities
292,073
287,556
298,981
254,393
Proceeds from maturities of available-for-sale investments
-
-
-
35,236
Proceeds from sale of available-for-sale investments
-
1,085
28,083
-
Purchases of available-for-sale investments
-
-
5,526
20,500
Proceeds from sale of ccxi investment
-
-
-
73,219
Additions to property and equipment
28,850
31,006
62,877
38,244
Acquisitions, net of cash acquired
-
-
169,707
101,184
Distributions from (investments in) wilson wolf
-
7,291
-
-
Proceeds from sale of eminence
-
-
-
17,824
Investment in spear bio
-
15,000
-
-
Distributions from wilson wolf
6,043
-
-
-
Investment in wilson wolf
-
-
-
232,000
Distributions from (investments in) wilson wolf
-
-
6,997
-
Proceeds from sale of assets held-for-sale
4,617
2,447
-
-
Net cash used in investing activities
-18,190
-35,183
-203,030
-265,649
Cash dividends
49,916
50,391
50,419
50,285
Proceeds from stock option exercises
80,618
51,739
60,935
29,813
Repurchases of common stock
41,675
275,731
80,042
19,562
Borrowings under line-of-credit agreement
-
104,000
225,000
619,661
Repayments of long-term debt
146,000
77,000
256,000
525,661
Taxes paid on rsus and net share settlements
12,141
6,522
21,872
28,893
Other financing activity
-
-
-
-2,457
Net cash used in financing activities
-169,114
-253,905
-122,398
22,616
Effect of exchange rate changes on cash and cash equivalents
-2,243
11,927
-2,333
-3,356
Net change in cash and cash equivalents
102,526
10,395
-28,780
8,004
Cash and cash equivalents at beginning of period
162,186
151,791
180,571
172,567
Cash and cash equivalents at end of period
264,712
162,186
151,791
180,571
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
TECH Cash Flow Sankey Diagram
Sankey diagram visualizing TECH cash flow for the period
Net earnings
$181,862K
(147.77%↑ Y/Y)
Depreciation and
amortization
$97,359K
(-11.41%↓ Y/Y)
Stock-based compensation
expense
$41,365K
(1.30%↑ Y/Y)
Deferred income taxes
$13,196K
(125.82%↑ Y/Y)
Loss on investments
-$5,862K
Prepaid expenses
-$5,264K
(-136.63%↓ Y/Y)
Asset impairment
restructuring
$3,914K
(-81.63%↓ Y/Y)
Trade accounts
payable, accrued...
$3,180K
(122.79%↑ Y/Y)
Other operating
activity
$477K
(-29.33%↓ Y/Y)
Net cash provided by
operating activities
$292,073K
(1.57%↑ Y/Y)
Canceled cashflow
$60,406K
Net change in cash
and cash...
$102,526K
(886.30%↑ Y/Y)
Canceled cashflow
$189,547K
Income taxes payable
-$23,051K
(-372.18%↓ Y/Y)
Trade accounts and
other receivables,...
$10,793K
(131.62%↑ Y/Y)
Inventories
$8,232K
(-54.63%↓ Y/Y)
Salaries, wages and
related accruals
-$7,671K
(-149.79%↓ Y/Y)
(recovery) impairment of
assets held-for-sale
-$6,789K
Leases, net
-$2,983K
(-535.47%↓ Y/Y)
(gain) loss on equity
method investment
$887K
(-5.44%↓ Y/Y)
Proceeds from stock
option exercises
$80,618K
(55.82%↑ Y/Y)
Distributions from wilson wolf
$6,043K
Proceeds from sale of
assets held-for-sale
$4,617K
(88.68%↑ Y/Y)
Net cash used in
financing activities
-$169,114K
(33.39%↑ Y/Y)
Net cash used in
investing activities
-$18,190K
(48.30%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$2,243K
(-118.81%↓ Y/Y)
Canceled cashflow
$80,618K
Canceled cashflow
$10,660K
Repayments of long-term
debt
$146,000K
(89.61%↑ Y/Y)
Cash dividends
$49,916K
(-0.94%↓ Y/Y)
Additions to property and
equipment
$28,850K
(-6.95%↓ Y/Y)
Repurchases of common stock
$41,675K
(-84.89%↓ Y/Y)
Taxes paid on rsus and
net share...
$12,141K
(86.15%↑ Y/Y)
Buy us a coffee
Show more